Form 10-Q ZS Pharma, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500, Dow futures muted after big bank earnings, chip slide weighs
- Oil prices ease as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Sysco calls on Teamsters to end LA strike after economic deal reached
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
ZS Pharma (ZSPH) Posts Q3 Loss of 41c/Share
November 9, 2015 3:26 PM ESTZS Pharma (Nasdaq: ZSPH) reported Q3 EPS of ($0.41), $0.63 better than the analyst estimate of ($1.04).
The company reported a loss of $0.81 per share in the same period last year.
For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.
... More


